title: The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus.
abstract: The yields of egg-grown influenza vaccines are maximized by the production of a seed strain using a reassortment of the seasonal influenza virus isolate with a highly egg-adapted strain. The seed virus is selected based on high yields of viral hemagglutinin (HA) and expression of the surface antigens from the seasonal isolate. The remaining proteins are usually derived from the high-growth parent. However, a retrospective analysis of vaccine seeds revealed that the seasonal PB1 gene was selected in more than 50% of reassortment events. Using the model seasonal H3N2 virus A/Udorn/307/72 (Udorn) virus and the high-growth A/Puerto Rico/8/34 (PR8) virus, we assessed the influence of the source of the PB1 gene on virus growth and vaccine yield. Classical reassortment of these two strains led to the selection of viruses that predominantly had the Udorn PB1 gene. The presence of Udorn PB1 in the seed virus, however, did not result in higher yields of virus or HA compared to the yields in the corresponding seed virus with PR8 PB1. The 8-fold-fewer virions produced with the seed virus containing the Udorn PB1 were somewhat compensated for by a 4-fold increase in HA per virion. A higher HA/nucleoprotein (NP) ratio was found in past vaccine preparations when the seasonal PB1 was present, also indicative of a higher HA density in these vaccine viruses. As the HA viral RNA (vRNA) and mRNA levels in infected cells were similar, we propose that PB1 selectively alters the translation of viral mRNA. This study helps to explain the variability of vaccine seeds with respect to HA yield.
authors.affiliation: Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia.
authors.forename: Joanna C A
authors.initials: JC
authors.lastname: Cobbin
authors.forename: Erin E
authors.initials: EE
authors.lastname: Verity
authors.forename: Brad P
authors.initials: BP
authors.lastname: Gilbertson
authors.forename: Steven P
authors.initials: SP
authors.lastname: Rockman
authors.forename: Lorena E
authors.initials: LE
authors.lastname: Brown
mesh_terms: D000818:Animals; D006388:Hemagglutinins / Q000032:analysis* / Q000276:immunology; D006801:Humans; D007252:Influenza Vaccines / Q000737:chemistry* / Q000276:immunology; D009975:Orthomyxoviridae / Q000737:chemistry* / Q000254:growth & development / Q000276:immunology; D016865:Reassortant Viruses / Q000737:chemistry* / Q000254:growth & development / Q000276:immunology; D013678:Technology, Pharmaceutical / Q000379:methods; D014764:Viral Proteins / Q000378:metabolism*
chemical_list: D006388:Hemagglutinins; D007252:Influenza Vaccines; D014764:Viral Proteins; C077346:influenza virus polymerase basic protein 1